New Ethics Rules: Health Officials Banned from Profiting from Drugs They Approved.
This law aims to boost public trust in major health agencies like the FDA and CDC by imposing strict limits on former high-ranking officials. These rules prevent conflicts of interest by stopping officials from immediately profiting from drugs or devices they regulated or approved while in office. For citizens, this means regulatory decisions regarding medical products should be more objective and trustworthy.
Key points
Top officials from health agencies (NIH, FDA, CDC) are banned for 8 years from serving on the boards of companies that manufacture or research drugs or medical devices.
Former employees involved in approving grants for specific medical products cannot profit financially from those products, facing potential fines and imprisonment.
High-ranking officials and their spouses must disclose any ownership or financial interest in patents related to drugs or medical devices.
Expired
Citizen Poll